Bristol-Myers Squibb: ‘This Is the Fastest Approval I’ve Seen’

Bristol-Myers Squibb (BMY) received FDA approval for treatment of lung cancer. Evercore ISI’s Mark Schoenebaum calls it the fastest approval he’s ever seen: Bloomberg News The Biologic License Application for Bristol-Myers’ PD-1 in squamous cancer was accepted LAST WEEK. The PDUFA was set in June. It was approved today. This is the fastest approval I’ve seen in my [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.